June 29, 2018 - By Edith Ladford

ZELDA THERAPEUTICS LTD. ORDINARY SHARES (OTCMKTS:ZLDAF) had an increase of its shorted shares by 3.3%. It was issued in June by FINRA the 9,400 shorted shares on ZLDAF. The up change of 3.3% from 9,100 shares was reported.

Ticker’s shares touched $0.0721 during the last trading session after 6.03% change.Currently Zelda Therapeutics Limited is after 0.00% change in last June 29, 2017. ZLDAF has 31,002 shares volume. ZLDAF underperformed the S&P 500 by 12.57%.

Zelda Therapeutics Limited, a bio-pharmaceutical company, focuses on developing a range of cannabinoid formulations for the treatment of various medical conditions in Australia.The company has $52.73 million market cap. The firm is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.Currently it has negative earnings. It has strategic alliances with Knop Laboratories and CannPal Pty Ltd; and partnerships with AusCann Limited and Aunt Zelda??s Inc, as well as the Complutens?? University, the Curtin University, and the Telethon Kids Institute.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: